{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:57:55Z","timestamp":1777489075935,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001697","name":"Keio University","doi-asserted-by":"publisher","award":["20200022"],"award-info":[{"award-number":["20200022"]}],"id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001697","name":"Keio University","doi-asserted-by":"publisher","award":["20180355"],"award-info":[{"award-number":["20180355"]}],"id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12475"],"award-info":[{"award-number":["24K12475"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K19414"],"award-info":[{"award-number":["21K19414"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03217"],"award-info":[{"award-number":["22H03217"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019356","name":"SGH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006062","name":"Foundation for Promotion of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.labinv.2024.102131","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T07:14:10Z","timestamp":1725606850000},"page":"102131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins"],"prefix":"10.1016","volume":"104","author":[{"given":"Kazunori","family":"Shojo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-9167","authenticated-orcid":false,"given":"Nobuyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatsugu","family":"Anno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiharu","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2024.102131_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.labinv.2024.102131_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.labinv.2024.102131_bib3","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.labinv.2024.102131_bib4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.labinv.2024.102131_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.labinv.2024.102131_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/eji.200425518","article-title":"B7-H3 promotes acute and chronic allograft rejection","volume":"35","author":"Wang","year":"2005","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.labinv.2024.102131_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni967","article-title":"The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses","volume":"4","author":"Suh","year":"2003","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.labinv.2024.102131_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/eji.200839028","article-title":"B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction","volume":"39","author":"Leitner","year":"2009","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.labinv.2024.102131_bib9","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jcmm.13143","article-title":"Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma","volume":"21","author":"Mao","year":"2017","journal-title":"J\u00a0Cell Mol Med"},{"issue":"6","key":"10.1016\/j.labinv.2024.102131_bib10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","article-title":"B7-H4, a molecule of the B7 family, negatively regulates T cell immunity","volume":"18","author":"Sica","year":"2003","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.labinv.2024.102131_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.celrep.2014.09.053","article-title":"Structure and cancer immunotherapy of the B7 family member B7x","volume":"9","author":"Jeon","year":"2014","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.labinv.2024.102131_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.20100619","article-title":"VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses","volume":"208","author":"Wang","year":"2011","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.labinv.2024.102131_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.it.2013.07.003","article-title":"B7 family checkpoint regulators in immune regulation and disease","volume":"34","author":"Ceeraz","year":"2013","journal-title":"Trends Immunol"},{"issue":"12","key":"10.1016\/j.labinv.2024.102131_bib14","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/modpathol.2017.89","article-title":"Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients","volume":"30","author":"Kakavand","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.labinv.2024.102131_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7-H3 and B7-H4 expression in non-small-cell lung cancer","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.labinv.2024.102131_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.labinv.2024.102131_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41551-020-0576-z","article-title":"Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies","volume":"4","author":"Tanaka","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"10.1016\/j.labinv.2024.102131_bib18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41551-017-0139-0","article-title":"Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity","volume":"1","author":"Tanaka","year":"2017","journal-title":"Nat Biomed Eng"},{"issue":"12","key":"10.1016\/j.labinv.2024.102131_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2024.102131_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2014.08.016","article-title":"Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis","volume":"70","author":"Stack","year":"2014","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.labinv.2024.102131_bib21","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/s41598-021-84787-5","article-title":"Pancancer survival analysis of cancer hallmark genes","volume":"11","author":"Nagy","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2024.102131_bib22","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gy\u0151rffy","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"10","key":"10.1016\/j.labinv.2024.102131_bib23","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s00262-021-03006-2","article-title":"Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma","volume":"70","author":"Murakami","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.labinv.2024.102131_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2022.100040","article-title":"Single-cell phenotyping of CD73 expression reveals the diversity of the tumor immune microenvironment and reflects the prognosis of bladder cancer","volume":"103","author":"Izawa","year":"2023","journal-title":"Lab Invest"},{"issue":"21","key":"10.1016\/j.labinv.2024.102131_bib25","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.labinv.2024.102131_bib26","article-title":"Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival","volume":"10","author":"Manitz","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"issue":"1","key":"10.1016\/j.labinv.2024.102131_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.labinv.2024.102131_bib28","doi-asserted-by":"crossref","first-page":"O8","DOI":"10.1186\/2051-1426-3-S2-O8","article-title":"Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3","volume":"3","author":"Powderly","year":"2015","journal-title":"J\u00a0Immunother Cancer"},{"issue":"4","key":"10.1016\/j.labinv.2024.102131_bib29","article-title":"Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I\/II trial","volume":"10","author":"Aggarwal","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.labinv.2024.102131_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx361.005","article-title":"FPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and ADCC activities","volume":"28","author":"Kaplan","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.labinv.2024.102131_bib31","doi-asserted-by":"crossref","first-page":"v405","DOI":"10.1093\/annonc\/mdx376.007","article-title":"CA-170, a first in class oral small molecule dual inhibitor of immune checkpoints PD-L1 and VISTA, demonstrates tumor growth inhibition in pre-clinical models and promotes T cell activation in Phase 1 study","volume":"28","author":"Powderly","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2024.102131_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/imr.12521","article-title":"The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3","volume":"276","author":"Janakiram","year":"2017","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.labinv.2024.102131_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-019-0540-1","article-title":"Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)","volume":"7","author":"Carvajal-Hausdorf","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"2","key":"10.1016\/j.labinv.2024.102131_bib34","article-title":"Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma","volume":"8","author":"Wang","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"11","key":"10.1016\/j.labinv.2024.102131_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.labinv.2024.102131_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724018099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724018099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:26:13Z","timestamp":1768249573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683724018099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0023683724018099"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102131","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102131"}}